Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Active not recruiting × Fulvestrant × Clear all

Phase

Phase 2 20 Phase 3 16 Phase 1 10 Phase 1/2 2 Phase 4 1 Phase 2/3 1

Status

Completed 2 Unknown 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Paclitaxel 9 Doxorubicin 8 Cyclophosphamide 8 Prednisone 7 Oxaliplatin 7 Docetaxel 7 Cisplatin 7 Capecitabine 6 Magnetic Resonance Spectroscopy 5 Leucovorin 5 Etoposide 5 Carboplatin 5 pembrolizumab 4 Specimen Handling 4 Gemcitabine 4 Fluorouracil 4 Cytarabine 4 Bevacizumab 4 atezolizumab 3 Watchful Waiting 3 Vincristine 3 Trastuzumab 3 Taxes 3 Rituximab 3 Epirubicin 3 Dexamethasone 3 Calcium Dobesilate 3 venetoclax 2 toripalimab 2 pertuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04191499 2026-03-17

INAVO120

Hoffmann-La Roche

Phase 2/3 Active not recruiting

325 enrolled 14 charts 1 FDA

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡